Eteplirsen
依特立生
Report date: 2026/03/10 20:00:16
NMEFirst In Class
Base Information
Drug NameEteplirsen
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2016/09/19
Country/Territory +[27]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSarepta Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesSarepta Therapeutics Inc
Inactive CompaniesAvi Biopharma International Ltd
Active Indications
Inactive IndicationsN/A